Albemarle (ALB) Financials

$56.61 +1.90 (+3.47%)

Closing price 04/11/2025 03:59 PM Eastern

Extended Trading

$55.88 -0.73 (-1.29%)

As of 04/11/2025 07:45 PM Eastern

Annual Income Statements for Albemarle

This table shows Albemarle's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	335	644	55	694	533	376	124	2,690	1,573	-1,316
Consolidated Net Income / (Loss)	360	681	99	739	604	447	200	2,815	1,671	-1,135
Net Income / (Loss) Continuing Operations	328	479	99	739	604	447	200	2,815	1,671	-1,135
Total Pre-Tax Income	311	515	447	795	563	374	134	2,433	247	-1,764
Total Operating Income	345	479	572	701	666	506	798	2,470	252	-1,777
Total Gross Profit	860	970	1,106	1,217	1,258	995	998	3,075	1,186	63
Total Revenue	2,826	2,677	3,072	3,375	3,589	3,129	3,328	7,320	9,617	5,378
Operating Revenue	2,826	2,677	3,072	3,375	3,589	3,129	3,328	7,320	9,617	5,378
Total Cost of Revenue	1,966	1,707	1,966	2,158	2,332	2,134	2,330	4,246	8,431	5,315
Operating Cost of Revenue	1,966	1,707	1,966	2,158	2,332	2,134	2,330	4,246	8,431	5,315
Total Operating Expenses	515	492	535	516	592	489	200	596	1,005	1,839
Selling, General & Admin Expense	300	354	450	446	533	430	441	524	910	618
Research & Development Expense	89	80	84	70	58	59	54	72	86	87
Restructuring Charge	125	57	-	-	-	-	-	0.00	9.49	1,134
Total Other Income / (Expense), net	-34	37	-125	94	-103	-132	-665	-45	66	13
Interest Expense	82	65	115	52	58	73	61	123	116	166
Other Income / (Expense), net	47	102	-9.51	146	-45	-59	-603	78	182	178
Income Tax Expense	11	96	432	145	88	54	29	391	430	87
Other Gains / (Losses), net	28	60	84	89	130	128	96	772	1,854	715
Preferred Stock Dividends Declared	-	-	-	-	-	-	-	0.00	0.00	137
Net Income / (Loss) Attributable to Noncontrolling Interest	25	37	45	46	71	71	76	125	97	44
Basic Earnings per Share	$3.01	$5.73	$0.49	$6.40	$5.03	$3.53	$1.07	$22.97	$13.41	($11.20)
Weighted Average Basic Shares Outstanding	111.18M	112.38M	110.91M	108.43M	105.95M	106.40M	115.84M	117.12M	117.32M	117.52M
Diluted Earnings per Share	$3.00	$5.68	$0.49	$6.34	$5.02	$3.52	$1.06	$22.84	$13.36	($11.20)
Weighted Average Diluted Shares Outstanding	111.56M	113.24M	112.38M	109.46M	106.32M	106.81M	116.54M	117.79M	117.77M	117.52M
Weighted Average Basic & Diluted Shares Outstanding	112.25M	112.57M	111.90M	108.40M	106.21M	116.63M	117.20M	-	117.40M	117.57M
Cash Dividends to Common per Share	$1.16	$1.22	$1.28	$1.34	$1.47	$1.54	$1.56	$1.58	$1.60	$1.61

This table shows Albemarle's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	897	1,132	1,239	650	303	-618	-9.14	-230	-1,111	34
Consolidated Net Income / (Loss)	931	1,162	1,277	676	321	-603	17	-177	-1,061	85
Net Income / (Loss) Continuing Operations	931	1,162	1,277	676	321	-603	17	-177	-1,061	85
Total Pre-Tax Income	869	863	1,157	168	-158	-921	-168	-494	-1,179	77
Total Operating Income	891	825	1,102	140	-140	-850	-180	-493	-1,109	4.40
Total Gross Profit	1,044	1,001	1,277	558	55	-704	39	-11	-104	138
Total Revenue	2,092	2,621	2,580	2,370	2,311	2,356	1,361	1,430	1,355	1,232
Operating Revenue	2,092	2,621	2,580	2,370	2,311	2,356	1,361	1,430	1,355	1,232
Total Cost of Revenue	1,048	1,620	1,304	1,812	2,256	3,060	1,322	1,441	1,459	1,094
Operating Cost of Revenue	1,048	1,620	1,304	1,812	2,256	3,060	1,322	1,441	1,459	1,094
Total Operating Expenses	153	168	175	418	195	217	218	482	1,005	134
Selling, General & Admin Expense	134	148	154	397	172	187	195	169	154	100
Research & Development Expense	18	20	20	21	21	23	24	21	22	20
Total Other Income / (Expense), net	-22	30	56	28	-18	0.11	12	-1.52	-70	72
Interest Expense	30	24	27	26	29	34	38	35	48	45
Other Income / (Expense), net	7.97	54	82	54	11	34	50	34	-22	117
Income Tax Expense	197	24	277	43	-8.55	119	-3.72	-31	111	11
Other Gains / (Losses), net	259	323	396	551	470	437	181	287	229	19
Preferred Stock Dividends Declared	-	-	0.00	0.00	0.00	-	12	42	42	42
Net Income / (Loss) Attributable to Noncontrolling Interest	34	29	38	26	18	14	14	12	8.35	9.82
Basic Earnings per Share	$7.66	$9.68	$10.57	$5.54	$2.58	($5.28)	($0.08)	($1.96)	($9.45)	$0.29
Weighted Average Basic Shares Outstanding	117.14M	117.12M	117.23M	117.33M	117.35M	117.32M	117.45M	117.53M	117.54M	117.52M
Diluted Earnings per Share	$7.61	$9.62	$10.51	$5.52	$2.57	($5.24)	($0.08)	($1.96)	($9.45)	$0.29
Weighted Average Diluted Shares Outstanding	117.87M	117.79M	117.84M	117.77M	117.78M	117.77M	117.45M	117.53M	117.54M	117.52M
Weighted Average Basic & Diluted Shares Outstanding	117.15M	0.00	117.34M	117.35M	117.35M	117.40M	117.53M	117.53M	117.54M	117.57M

This table details how cash moves in and out of Albemarle's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-2,276	2,056	-1,132	-544	58	134	-307	1,060	-609	302
Net Cash From Operating Activities	361	736	304	546	719	799	344	1,908	1,325	702
Net Cash From Continuing Operating Activities	361	736	304	546	719	799	344	1,908	1,325	702
Net Income / (Loss) Continuing Operations	360	681	99	739	604	447	200	2,815	1,671	-1,135
Consolidated Net Income / (Loss)	360	681	99	739	604	447	200	2,815	1,671	-1,135
Depreciation Expense	260	226	197	201	213	232	254	301	430	589
Non-Cash Adjustments To Reconcile Net Income	-81	-432	172	-291	1.48	209	-183	113	639	121
Changes in Operating Assets and Liabilities, net	-178	260	-165	-103	-100	-89	73	-1,321	-1,414	1,128
Net Cash From Investing Activities	-2,161	2,920	-358	-304	-1,664	-864	-667	-1,423	-2,781	-1,574
Net Cash From Continuing Investing Activities	-2,161	2,920	-358	-304	-1,664	-864	-667	-1,423	-2,781	-1,574
Purchase of Property, Plant & Equipment	-228	-197	-318	-700	-852	-850	-954	-1,262	-2,149	-1,686
Acquisitions	-2,100	-209	-44	-11	-820	-23	0.00	-162	-426	0.00
Purchase of Investments	1.00	0.00	-3.84	-5.87	-2.57	-2.43	-6.49	-0.71	-1.20	-0.27
Sale of Property, Plant & Equipment	-	-	0.00	0.00	10	-	-	0.00	0.00	29
Sale and/or Maturity of Investments	98	0.31	-	-	0.38	0.90	3.77	1.94	-204	83
Net Cash From Financing Activities	-478	-1,580	-1,087	-787	1,043	177	50	612	624	1,242
Net Cash From Continuing Financing Activities	-478	-1,580	-1,087	-787	1,043	177	50	612	624	1,242
Repayment of Debt	-2,580	-1,416	-825	-114	-314	-116	-1,140	-1,113	588	-747
Payment of Dividends	-143	-171	-177	-159	-235	-194	-274	-229	-293	-348
Issuance of Debt	2,250	0.00	166	0.00	1,598	452	0.00	1,964	356	112
Issuance of Preferred Equity	-	-	-	-	-	-	-	0.00	0.00	2,237
Other Financing Activities, net	-1.03	7.21	-0.14	-14	-6.22	35	10	-11	-27	-12
Effect of Exchange Rate Changes	2.15	-20	8.24	-	-41	21	-35	-37	223	-67

This table details how cash moves in and out of Albemarle's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	452	116	88	13	1.93	-712	1,166	-226	-166	-472
Net Cash From Operating Activities	895	952	721	74	629	-98	98	363	241	0.67
Net Cash From Continuing Operating Activities	895	952	721	74	629	-98	98	363	241	0.67
Net Income / (Loss) Continuing Operations	931	1,162	1,277	676	321	-603	17	-177	-1,061	85
Consolidated Net Income / (Loss)	931	1,162	1,277	676	321	-603	17	-177	-1,061	85
Depreciation Expense	78	86	87	93	105	144	124	138	164	163
Non-Cash Adjustments To Reconcile Net Income	-36	100	107	-146	417	261	-107	133	759	-665
Changes in Operating Assets and Liabilities, net	-78	-395	-750	-550	-215	100	64	268	379	417
Net Cash From Investing Activities	-313	-609	-539	-514	-663	-1,066	-495	-450	-302	-328
Net Cash From Continuing Investing Activities	-313	-609	-539	-514	-663	-1,066	-495	-450	-302	-328
Purchase of Property, Plant & Equipment	-313	-446	-416	-504	-546	-684	-579	-448	-303	-356
Purchase of Investments	0.26	-0.20	-1.13	-0.06	-0.09	0.08	-0.07	83	-83	-0.05
Sale and/or Maturity of Investments	-0.27	-1.19	-122	-1.71	-82	1.50	85	-	-	-1.13
Net Cash From Financing Activities	-65	-299	-119	246	100	397	1,557	-113	-110	-93
Net Cash From Continuing Financing Activities	-65	-299	-119	246	100	397	1,557	-113	-110	-93
Repayment of Debt	-0.49	-253	-0.71	-0.79	174	415	-651	-36	-30	-31
Payment of Dividends	-64	-46	-99	-47	-73	-73	-47	-105	-108	-89
Issuance of Debt	-	-	0.00	300	-	56	29	27	28	28
Other Financing Activities, net	-0.83	0.01	-19	-6.29	-1.22	-1.23	-11	-0.06	-0.19	-0.74
Effect of Exchange Rate Changes	-64	73	24	-	-	55	-	-	5.83	-52

This table presents Albemarle's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	9,598	8,161	7,751	7,582	9,861	10,451	15,457	15,457	18,271	16,610
Total Current Assets	1,831	3,307	2,478	1,998	2,225	2,206	5,187	5,187	5,217	3,842
Cash & Equivalents	214	2,270	1,137	555	613	747	1,499	1,499	890	1,192
Accounts Receivable	473	528	572	658	680	593	1,377	1,377	1,722	981
Inventories, net	440	450	593	701	769	750	2,076	2,076	2,161	1,503
Other Current Assets	63	59	136	85	163	116	235	235	443	167
Plant, Property, & Equipment, net	2,321	2,360	2,493	3,021	4,909	5,355	6,963	6,963	9,495	9,331
Plant, Property & Equipment, gross	3,700	3,911	4,124	4,799	6,818	7,428	9,354	9,354	12,234	12,523
Accumulated Depreciation	1,379	1,550	1,631	1,778	1,908	2,073	2,391	2,391	2,739	3,192
Total Noncurrent Assets	5,446	2,494	2,780	2,562	2,726	2,890	3,307	3,307	3,559	3,436
Long-Term Investments	436	458	534	529	580	656	1,151	1,151	1,370	1,118
Goodwill	1,461	1,540	1,610	1,567	1,579	1,666	1,618	1,618	1,630	1,583
Intangible Assets	384	355	422	386	355	349	288	288	262	231
Other Noncurrent Operating Assets	194	142	74	80	213	219	251	251	297	505
Total Liabilities & Shareholders' Equity	9,598	8,161	7,751	7,582	9,861	10,451	15,457	15,457	18,271	16,610
Total Liabilities	6,197	4,219	3,933	3,823	5,767	5,982	7,266	7,266	8,606	6,410
Total Current Liabilities	1,617	1,140	1,201	1,183	1,409	1,802	2,741	2,741	3,560	1,966
Short-Term Debt	675	248	422	307	187	805	2.13	2.13	626	398
Accounts Payable	240	282	419	523	574	483	2,052	2,052	2,088	944
Accrued Expenses	313	322	268	257	576	441	506	506	545	468
Dividends Payable	32	34	35	35	39	41	46	46	47	61
Current Deferred & Payable Income Tax Liabilities	27	254	55	61	32	32	135	135	255	95
Total Noncurrent Liabilities	4,580	3,079	2,732	2,639	4,358	4,181	4,525	4,525	5,045	4,443
Long-Term Debt	3,142	2,122	1,415	1,398	2,863	2,767	3,215	3,215	3,541	3,118
Noncurrent Deferred & Payable Income Tax Liabilities	385	413	370	383	398	395	481	481	558	358
Noncurrent Employee Benefit Liabilities	350	349	347	332	343	389	192	192	177	148
Other Noncurrent Operating Liabilities	239	195	599	527	755	629	637	637	769	819
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,401	3,943	3,818	3,759	4,094	4,469	8,191	8,191	9,665	10,200
Total Preferred & Common Equity	3,254	3,795	3,675	3,585	3,932	4,268	7,983	7,983	9,412	9,962
Preferred Stock	-	-	-	-	-	-	-	-	0.00	2,235
Total Common Equity	3,254	3,795	3,675	3,585	3,932	4,268	7,983	7,983	9,412	7,726
Common Stock	2,060	2,086	1,865	1,370	1,385	1,439	2,942	2,942	2,954	2,987
Retained Earnings	1,615	2,122	2,035	2,566	2,943	3,155	5,601	5,601	6,987	5,482
Accumulated Other Comprehensive Income / (Loss)	-421	-412	-226	-351	-396	-326	-561	-561	-529	-742
Noncontrolling Interest	147	148	143	174	161	200	208	208	253	238

This table presents Albemarle's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	13,829	15,457	17,564	19,110	18,883	18,271	19,032	18,388	17,455	16,610
Total Current Assets	4,297	5,187	6,658	7,455	7,126	5,217	5,823	5,226	4,670	3,842
Cash & Equivalents	1,383	1,499	1,587	1,600	1,602	890	2,056	1,830	1,665	1,192
Accounts Receivable	1,171	1,377	1,664	1,771	1,708	1,722	1,313	1,198	1,018	981
Inventories, net	1,614	2,076	3,181	3,659	3,404	2,161	1,905	1,800	1,658	1,503
Other Current Assets	129	235	226	425	412	443	550	398	329	167
Plant, Property, & Equipment, net	6,425	6,963	7,353	7,855	8,309	9,495	9,756	9,837	9,258	9,331
Plant, Property & Equipment, gross	8,714	9,354	9,830	10,397	10,929	12,234	12,588	12,789	12,376	12,523
Accumulated Depreciation	2,289	2,391	2,477	2,542	2,621	2,739	2,832	2,952	3,118	3,192
Total Noncurrent Assets	3,106	3,307	3,553	3,800	3,449	3,559	3,454	3,326	3,527	3,436
Long-Term Investments	1,159	1,151	1,391	1,621	1,254	1,370	1,259	1,161	1,180	1,118
Goodwill	1,468	1,618	1,634	1,635	1,606	1,630	1,614	1,601	1,638	1,583
Intangible Assets	263	288	285	274	261	262	252	243	246	231
Other Noncurrent Operating Assets	217	251	243	270	329	297	329	321	464	505
Total Liabilities & Shareholders' Equity	13,829	15,457	17,564	19,110	18,883	18,271	19,032	18,388	17,455	16,610
Total Liabilities	6,864	7,266	8,105	9,022	8,721	8,606	7,233	6,905	6,965	6,410
Total Current Liabilities	2,488	2,741	3,505	4,292	3,942	3,560	2,051	1,958	1,911	1,966
Short-Term Debt	251	2.13	2.17	6.25	162	626	5.08	3.21	3.01	398
Accounts Payable	1,652	2,052	2,771	3,052	2,607	2,088	1,296	1,323	1,223	944
Accrued Expenses	385	506	403	673	689	545	455	508	513	468
Dividends Payable	46	46	47	47	47	47	58	61	61	61
Current Deferred & Payable Income Tax Liabilities	153	135	282	513	436	255	237	63	111	95
Total Noncurrent Liabilities	4,376	4,525	4,600	4,730	4,779	5,045	5,182	4,947	5,054	4,443
Long-Term Debt	3,119	3,215	3,233	3,509	3,496	3,541	3,519	3,520	3,566	3,118
Noncurrent Deferred & Payable Income Tax Liabilities	429	481	486	328	290	558	657	501	526	358
Noncurrent Employee Benefit Liabilities	230	192	193	192	187	177	171	168	170	148
Other Noncurrent Operating Liabilities	598	637	687	701	807	769	834	758	792	819
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,965	8,191	9,459	10,088	10,162	9,665	11,800	11,483	10,491	10,200
Total Preferred & Common Equity	6,733	7,983	9,213	9,815	9,898	9,412	11,533	11,223	10,241	9,962
Preferred Stock	-	-	-	-	-	0.00	2,235	2,235	2,235	2,235
Total Common Equity	6,733	7,983	9,213	9,815	9,898	9,412	9,297	8,987	8,005	7,726
Common Stock	2,935	2,942	2,933	2,937	2,947	2,954	2,964	2,971	2,980	2,987
Retained Earnings	4,515	5,601	6,793	7,396	7,652	6,987	6,931	6,654	5,496	5,482
Accumulated Other Comprehensive Income / (Loss)	-717	-561	-513	-518	-701	-529	-597	-638	-470	-742
Noncontrolling Interest	232	208	246	273	265	253	267	261	250	238

This table displays calculated financial ratios and metrics derived from Albemarle's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.57%	-5.28%	14.75%	9.86%	6.36%	-12.83%	6.36%	119.96%	31.38%	-44.08%
EBITDA Growth	82.20%	23.62%	-5.89%	38.04%	-20.39%	-18.64%	-33.82%	534.36%	-69.67%	-216.86%
EBIT Growth	54.16%	47.92%	-3.15%	50.69%	-26.73%	-28.04%	-56.32%	1,206.05%	-82.97%	-468.25%
NOPAT Growth	34.29%	16.98%	-95.08%	2,891.20%	-2.01%	-23.09%	44.06%	233.12%	-109.04%	-563.72%
Net Income Growth	123.77%	89.07%	-85.39%	643.09%	-18.24%	-26.10%	-55.23%	1,307.97%	-40.66%	-167.97%
EPS Growth	77.51%	89.33%	-91.37%	1,193.88%	-20.82%	-29.88%	-69.89%	2,054.72%	-41.51%	-183.83%
Operating Cash Flow Growth	-26.76%	103.85%	-58.67%	79.67%	31.71%	11.06%	-56.91%	454.19%	-30.53%	-47.03%
Free Cash Flow Firm Growth	-364.37%	132.71%	-137.04%	100.17%	-289,677.35%	74.63%	-485.31%	237.94%	-244.76%	63.62%
Invested Capital Growth	114.83%	-4.32%	6.18%	14.91%	35.65%	11.50%	31.83%	0.00%	31.97%	-1.30%
Revenue Q/Q Growth	-2.35%	6.62%	5.54%	1.93%	2.01%	-3.50%	0.45%	30.87%	-2.68%	-17.29%
EBITDA Q/Q Growth	46.72%	-7.05%	10.65%	-1.76%	-4.03%	-3.98%	-12.45%	46.09%	-65.55%	50.43%
EBIT Q/Q Growth	79.10%	-8.10%	14.19%	-1.87%	-6.28%	-6.90%	-26.50%	52.89%	-79.69%	38.68%
NOPAT Q/Q Growth	108.47%	-19.68%	-95.15%	73.98%	37.74%	-2.50%	-33.29%	69.97%	-111.65%	32.47%
Net Income Q/Q Growth	120.47%	168.87%	-89.15%	91.48%	-6.18%	-0.90%	-31.44%	69.20%	-51.38%	37.74%
EPS Q/Q Growth	147.93%	194.30%	-93.67%	100.00%	-7.04%	-1.68%	-43.92%	73.29%	-52.66%	33.05%
Operating Cash Flow Q/Q Growth	-4.79%	47.69%	-14.67%	-9.89%	39.72%	-4.37%	-58.41%	135.75%	-44.22%	16.40%
Free Cash Flow Firm Q/Q Growth	62.40%	-83.47%	29.24%	-99.91%	-125.68%	75.82%	-240.15%	1,445.26%	-91.90%	48.17%
Invested Capital Q/Q Growth	-41.47%	0.40%	-10.40%	4.06%	17.46%	1.12%	36.18%	12.31%	5.51%	1.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.44%	36.24%	36.01%	36.07%	35.04%	31.80%	29.99%	42.00%	12.33%	1.16%
EBITDA Margin	23.08%	30.13%	24.71%	31.05%	23.24%	21.69%	13.49%	38.92%	8.98%	-18.77%
Operating Margin	12.21%	17.88%	18.61%	20.77%	18.56%	16.17%	23.99%	33.74%	2.62%	-33.04%
EBIT Margin	13.88%	21.68%	18.30%	25.10%	17.29%	14.27%	5.86%	34.81%	4.51%	-29.72%
Profit (Net Income) Margin	12.74%	25.43%	3.24%	21.90%	16.84%	14.27%	6.01%	38.46%	17.37%	-21.12%
Tax Burden Percent	115.87%	132.12%	22.26%	93.01%	107.36%	119.57%	149.64%	115.69%	677.05%	64.38%
Interest Burden Percent	79.19%	88.77%	79.48%	93.81%	90.70%	83.63%	68.49%	95.50%	56.85%	110.36%
Effective Tax Rate	3.58%	18.68%	96.65%	18.22%	15.66%	14.57%	22.04%	16.05%	174.39%	0.00%
Return on Invested Capital (ROIC)	12.01%	10.52%	0.51%	13.89%	10.80%	6.82%	8.04%	23.55%	-1.83%	-10.77%
ROIC Less NNEP Spread (ROIC-NNEP)	20.38%	1,039.88%	-53.17%	62.57%	14.13%	7.53%	-21.89%	144.42%	142.91%	-4.06%
Return on Net Nonoperating Assets (RNNOA)	2.72%	8.02%	2.05%	5.62%	4.59%	3.61%	-4.88%	12.66%	20.55%	-0.66%
Return on Equity (ROE)	14.73%	18.54%	2.56%	19.51%	15.39%	10.43%	3.16%	36.21%	18.71%	-11.43%
Cash Return on Invested Capital (CROIC)	-60.94%	14.93%	-5.48%	0.01%	-19.46%	-4.05%	-19.42%	23.55%	-29.40%	-9.46%
Operating Return on Assets (OROA)	5.30%	6.54%	7.07%	11.05%	7.12%	4.40%	1.51%	19.28%	2.57%	-9.16%
Return on Assets (ROA)	4.86%	7.67%	1.25%	9.64%	6.93%	4.40%	1.54%	21.30%	9.91%	-6.51%
Return on Common Equity (ROCE)	13.90%	17.80%	2.47%	18.69%	14.74%	9.99%	3.06%	35.21%	18.23%	-9.86%
Return on Equity Simple (ROE_SIMPLE)	11.06%	17.94%	2.71%	20.62%	15.37%	10.46%	2.50%	35.27%	17.75%	-11.40%
Net Operating Profit after Tax (NOPAT)	333	389	19	573	562	432	622	2,074	-187	-1,244
NOPAT Margin	11.77%	14.54%	0.62%	16.99%	15.65%	13.81%	18.70%	28.33%	-1.95%	-23.13%
Net Nonoperating Expense Percent (NNEP)	-8.38%	-1,029.36%	53.68%	-48.69%	-3.33%	-0.71%	29.93%	-120.87%	-144.74%	-6.71%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	18.18%	-1.35%	-9.07%
Cost of Revenue to Revenue	69.56%	63.76%	63.99%	63.93%	64.96%	68.20%	70.01%	58.00%	87.67%	98.84%
SG&A Expenses to Revenue	10.63%	13.21%	14.66%	13.22%	14.86%	13.74%	13.27%	7.16%	9.46%	11.49%
R&D to Revenue	3.16%	3.01%	2.75%	2.08%	1.62%	1.89%	1.62%	0.98%	0.89%	1.61%
Operating Expenses to Revenue	18.23%	18.36%	17.40%	15.29%	16.48%	15.63%	6.00%	8.14%	10.45%	34.20%
Earnings before Interest and Taxes (EBIT)	392	580	562	847	621	447	195	2,548	434	-1,598
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	652	807	759	1,048	834	679	449	2,849	864	-1,010
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.73	2.33	3.55	2.13	1.88	3.57	3.35	3.11	1.77	1.31
Price to Tangible Book Value (P/TBV)	4.00	4.65	7.93	4.69	3.70	6.76	4.40	4.08	2.22	1.71
Price to Revenue (P/Rev)	2.00	3.30	4.24	2.27	2.06	4.87	8.04	3.39	1.74	1.88
Price to Earnings (P/E)	16.84	13.72	237.54	11.03	13.86	40.55	216.29	9.22	10.61	0.00
Dividend Yield	2.31%	1.55%	1.09%	1.86%	2.11%	1.08%	0.68%	0.75%	1.12%	1.87%
Earnings Yield	5.94%	7.29%	0.42%	9.06%	7.22%	2.47%	0.46%	10.85%	9.42%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.37	2.38	3.47	1.91	1.57	2.64	3.13	2.91	1.62	1.20
Enterprise Value to Revenue (EV/Rev)	3.17	3.22	4.34	2.50	2.62	5.63	8.27	3.49	1.96	2.57
Enterprise Value to EBITDA (EV/EBITDA)	13.72	10.69	17.57	8.06	11.28	25.95	61.29	8.98	21.83	0.00
Enterprise Value to EBIT (EV/EBIT)	22.82	14.85	23.73	9.97	15.16	39.42	141.08	10.04	43.45	0.00
Enterprise Value to NOPAT (EV/NOPAT)	26.91	22.14	695.88	14.73	16.75	40.75	44.22	12.33	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	24.82	11.72	43.88	15.47	13.08	22.04	79.95	13.41	14.23	19.65
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	15.60	0.00	24,163.36	0.00	0.00	0.00	12.33	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.12	0.60	0.48	0.45	0.75	0.80	0.39	0.39	0.43	0.34
Long-Term Debt to Equity	0.92	0.54	0.37	0.37	0.70	0.62	0.39	0.39	0.37	0.31
Financial Leverage	0.13	0.01	-0.04	0.09	0.33	0.48	0.22	0.09	0.14	0.16
Leverage Ratio	3.03	2.42	2.05	2.02	2.22	2.37	2.05	1.89	1.89	1.76
Compound Leverage Factor	2.40	2.15	1.63	1.90	2.01	1.98	1.40	1.80	1.07	1.94
Debt to Total Capital	52.88%	37.54%	32.49%	31.21%	42.70%	44.43%	28.20%	28.20%	30.12%	25.64%
Short-Term Debt to Total Capital	9.35%	3.92%	7.46%	5.62%	2.62%	10.01%	0.02%	0.02%	4.52%	2.90%
Long-Term Debt to Total Capital	43.53%	33.61%	25.03%	25.58%	40.08%	34.42%	28.18%	28.18%	25.60%	22.73%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	16.30%
Noncontrolling Interests to Total Capital	2.04%	2.34%	2.53%	3.18%	2.26%	2.49%	1.83%	1.83%	1.83%	1.74%
Common Equity to Total Capital	45.08%	60.13%	64.98%	65.61%	55.04%	53.08%	69.97%	69.97%	68.05%	56.33%
Debt to EBITDA	5.85	2.94	2.42	1.63	3.66	5.26	7.16	1.13	4.82	-3.48
Net Debt to EBITDA	4.86	-0.44	0.22	0.59	2.23	3.20	1.26	0.20	2.21	-1.19
Long-Term Debt to EBITDA	4.82	2.63	1.86	1.33	3.43	4.08	7.16	1.13	4.10	-3.09
Debt to NOPAT	11.47	6.09	95.86	2.97	5.43	8.27	5.17	1.55	-22.24	-2.83
Net Debt to NOPAT	9.52	-0.92	8.66	1.08	3.31	5.02	0.91	0.27	-10.18	-0.97
Long-Term Debt to NOPAT	9.44	5.45	73.84	2.44	5.10	6.40	5.16	1.55	-18.90	-2.51
Altman Z-Score	1.24	2.50	3.19	2.62	1.86	2.44	3.16	3.76	2.41	1.55
Noncontrolling Interest Sharing Ratio	5.65%	4.01%	3.75%	4.18%	4.27%	4.22%	3.23%	2.78%	2.58%	13.72%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.13	2.90	2.06	1.69	1.58	1.22	1.89	1.89	1.47	1.95
Quick Ratio	0.42	2.45	1.42	1.03	0.92	0.74	1.05	1.05	0.73	1.10
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,689	552	-205	0.35	-1,012	-257	-1,503	2,074	-3,002	-1,092
Operating Cash Flow to CapEx	158.49%	374.02%	95.68%	78.02%	85.49%	93.94%	36.10%	151.22%	61.66%	42.38%
Free Cash Flow to Firm to Interest Expense	-20.68	8.48	-1.77	0.01	-17.55	-3.51	-24.45	16.86	-25.86	-6.59
Operating Cash Flow to Interest Expense	4.42	11.28	2.64	10.42	12.47	10.93	5.60	15.51	11.42	4.24
Operating Cash Flow Less CapEx to Interest Expense	1.63	8.27	-0.12	-2.94	-2.12	-0.71	-9.91	5.25	-7.10	-5.76
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.38	0.30	0.39	0.44	0.41	0.31	0.26	0.55	0.57	0.31
Accounts Receivable Turnover	6.23	5.35	5.58	5.49	5.37	4.92	3.38	7.32	6.21	3.98
Inventory Turnover	4.93	3.84	3.77	3.34	3.17	2.81	1.65	2.95	3.98	2.90
Fixed Asset Turnover	1.59	1.14	1.27	1.22	0.91	0.61	0.54	1.14	1.17	0.57
Accounts Payable Turnover	8.34	6.55	5.61	4.59	4.25	4.04	1.84	3.14	4.07	3.51
Days Sales Outstanding (DSO)	58.60	68.23	65.37	66.51	68.03	74.25	108.01	49.86	58.81	91.73
Days Inventory Outstanding (DIO)	74.06	95.13	96.84	109.39	115.02	129.92	221.37	123.57	91.72	125.80
Days Payable Outstanding (DPO)	43.74	55.75	65.03	79.60	85.84	90.42	198.58	116.06	89.61	104.11
Cash Conversion Cycle (CCC)	88.91	107.61	97.18	96.31	97.21	113.75	130.81	57.37	60.91	113.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,782	3,619	3,842	4,415	5,990	6,679	8,804	8,804	11,619	11,467
Invested Capital Turnover	1.02	0.72	0.82	0.82	0.69	0.49	0.43	0.83	0.94	0.47
Increase / (Decrease) in Invested Capital	2,021	-163	224	573	1,574	689	2,126	0.00	2,814	-152
Enterprise Value (EV)	8,954	8,619	13,338	8,448	9,408	17,607	27,525	25,577	18,856	13,797
Market Capitalization	5,639	8,829	13,029	7,653	7,390	15,238	26,749	24,802	16,696	10,118
Book Value per Share	$29.00	$33.74	$33.26	$33.76	$37.09	$40.09	$68.24	$68.14	$80.20	$65.73
Tangible Book Value per Share	$12.57	$16.90	$14.87	$15.37	$18.85	$21.17	$51.95	$51.87	$64.09	$50.31
Total Capital	7,218	6,312	5,655	5,464	7,144	8,041	11,408	11,408	13,832	13,716
Total Debt	3,817	2,369	1,837	1,705	3,050	3,572	3,217	3,217	4,167	3,516
Total Long-Term Debt	3,142	2,122	1,415	1,398	2,863	2,767	3,215	3,215	3,541	3,118
Net Debt	3,168	-358	166	621	1,857	2,169	567	567	1,907	1,206
Capital Expenditures (CapEx)	228	197	318	700	841	850	954	1,262	2,149	1,657
Debt-free, Cash-free Net Working Capital (DFCFNWC)	676	144	561	567	390	462	949	949	1,392	1,082
Debt-free Net Working Capital (DFNWC)	889	2,414	1,699	1,123	1,003	1,209	2,448	2,448	2,282	2,274
Net Working Capital (NWC)	214	2,167	1,277	815	816	404	2,446	2,446	1,656	1,876
Net Nonoperating Expense (NNE)	-27	-292	-80	-166	-43	-15	423	-742	-1,858	-108
Net Nonoperating Obligations (NNO)	381	-324	25	656	1,896	2,210	614	614	1,954	1,267
Total Depreciation and Amortization (D&A)	260	226	197	201	213	232	254	301	430	589
Debt-free, Cash-free Net Working Capital to Revenue	23.90%	5.39%	18.27%	16.81%	10.87%	14.77%	28.51%	12.96%	14.48%	20.11%
Debt-free Net Working Capital to Revenue	31.46%	90.17%	55.30%	33.26%	27.96%	38.64%	73.56%	33.44%	23.73%	42.28%
Net Working Capital to Revenue	7.58%	80.92%	41.56%	24.16%	22.74%	12.92%	73.50%	33.41%	17.22%	34.88%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.01	$0.00	$0.49	$6.40	$5.03	$3.53	$0.00	$0.00	$13.41	($11.20)
Adjusted Weighted Average Basic Shares Outstanding	111.18M	0.00	110.91M	108.43M	105.95M	106.40M	0.00	0.00	117.32M	117.52M
Adjusted Diluted Earnings per Share	$3.00	$0.00	$0.49	$6.34	$5.02	$3.52	$0.00	$0.00	$13.36	($11.20)
Adjusted Weighted Average Diluted Shares Outstanding	111.56M	0.00	112.38M	109.46M	106.32M	106.81M	0.00	0.00	117.77M	117.52M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	112.25M	0.00	110.64M	105.75M	106.21M	116.63M	0.00	0.00	117.40M	117.57M
Normalized Net Operating Profit after Tax (NOPAT)	454	436	400	573	562	432	622	2,074	183	-450
Normalized NOPAT Margin	16.05%	16.28%	13.03%	16.99%	15.65%	13.81%	18.70%	28.33%	1.90%	-8.36%
Pre Tax Income Margin	10.99%	19.25%	14.54%	23.55%	15.68%	11.94%	4.02%	33.24%	2.57%	-32.80%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.81	8.91	4.87	16.16	10.76	6.11	3.17	20.72	3.74	-9.65
NOPAT to Interest Expense	4.08	5.97	0.17	10.94	9.74	5.91	10.13	16.86	-1.61	-7.51
EBIT Less CapEx to Interest Expense	2.02	5.89	2.12	2.81	-3.83	-5.52	-12.34	10.46	-14.78	-19.65
NOPAT Less CapEx to Interest Expense	1.29	2.95	-2.59	-2.42	-4.85	-5.72	-5.39	6.60	-20.13	-17.51
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	39.60%	25.15%	178.26%	21.56%	38.95%	43.41%	137.03%	8.12%	17.53%	-30.69%
Augmented Payout Ratio	40.93%	25.15%	429.60%	89.21%	38.95%	43.41%	137.03%	8.12%	17.53%	-30.69%

This table displays calculated financial ratios and metrics derived from Albemarle's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	151.85%	193.11%	128.80%	60.19%	10.46%	-10.10%	-47.26%	-39.65%	-41.37%	-47.72%
EBITDA Growth	317.23%	1,372.67%	222.68%	-44.14%	-102.39%	-169.61%	-100.46%	-211.72%	-4,037.27%	142.39%
EBIT Growth	275.69%	31,984.18%	261.63%	-56.21%	-114.33%	-192.79%	-110.94%	-336.63%	-777.95%	114.89%
NOPAT Growth	648.50%	3,760.16%	257.75%	-69.14%	-114.22%	-174.22%	-114.99%	-430.75%	-691.94%	100.64%
Net Income Growth	348.70%	10,997.39%	353.46%	53.53%	-65.56%	-151.93%	-98.70%	-126.11%	-430.73%	114.11%
EPS Growth	326.49%	24,150.00%	388.84%	59.54%	-66.23%	-154.47%	-100.76%	-135.51%	-467.70%	105.53%
Operating Cash Flow Growth	754.83%	750.76%	249.69%	150.53%	-29.76%	-110.31%	-86.41%	392.34%	-61.75%	100.69%
Free Cash Flow Firm Growth	-395.89%	137.32%	-567.02%	-159.71%	-377.42%	-525.32%	-38.42%	15.45%	68.16%	104.56%
Invested Capital Growth	21.25%	0.00%	36.18%	30.86%	40.47%	31.97%	23.60%	15.79%	2.41%	-1.30%
Revenue Q/Q Growth	41.38%	25.30%	-1.55%	-8.14%	-2.51%	1.97%	-42.25%	5.12%	-5.29%	-9.08%
EBITDA Q/Q Growth	90.07%	-1.27%	30.72%	-77.43%	-108.15%	-2,770.11%	99.21%	-5,377.72%	-201.74%	129.41%
EBIT Q/Q Growth	102.99%	-2.25%	33.49%	-83.62%	-166.42%	-532.90%	85.38%	-254.11%	-146.45%	110.74%
NOPAT Q/Q Growth	103.98%	16.32%	4.56%	-87.56%	-194.01%	-506.99%	78.88%	-174.43%	-125.09%	100.49%
Net Income Q/Q Growth	111.35%	24.76%	9.89%	-47.02%	-52.59%	-288.12%	102.76%	-1,160.82%	-500.61%	108.02%
EPS Q/Q Growth	119.94%	26.41%	9.25%	-47.48%	-53.44%	-303.89%	98.47%	-2,350.00%	-382.14%	103.07%
Operating Cash Flow Q/Q Growth	713.78%	6.36%	-24.29%	-89.78%	753.18%	-115.62%	199.73%	270.47%	-33.71%	-99.72%
Free Cash Flow Firm Q/Q Growth	24.46%	217.02%	-319.02%	-34.15%	-38.86%	-4.25%	28.72%	18.05%	47.71%	114.92%
Invested Capital Q/Q Growth	-1.63%	12.31%	10.89%	6.82%	5.59%	5.51%	3.86%	0.07%	-6.62%	1.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.90%	38.20%	49.47%	23.56%	2.38%	-29.88%	2.86%	-0.74%	-7.68%	11.22%
EBITDA Margin	46.69%	36.79%	49.28%	12.11%	-1.01%	-28.49%	-0.43%	-22.42%	-71.42%	23.10%
Operating Margin	42.59%	31.46%	42.70%	5.91%	-6.06%	-36.07%	-13.19%	-34.44%	-81.85%	0.36%
EBIT Margin	42.97%	33.53%	45.90%	8.18%	-5.58%	-34.61%	-9.52%	-32.09%	-83.49%	9.86%
Profit (Net Income) Margin	44.52%	44.33%	49.48%	28.54%	13.88%	-25.60%	1.22%	-12.35%	-78.29%	6.91%
Tax Burden Percent	107.13%	134.61%	110.30%	401.75%	-202.76%	65.51%	-9.93%	35.74%	89.97%	110.93%
Interest Burden Percent	96.70%	98.22%	97.74%	86.81%	122.77%	112.95%	129.30%	107.67%	104.22%	63.19%
Effective Tax Rate	22.66%	2.79%	23.93%	25.53%	0.00%	0.00%	0.00%	0.00%	0.00%	13.83%
Return on Invested Capital (ROIC)	25.76%	25.43%	33.66%	4.62%	-4.45%	-23.78%	-7.10%	-15.98%	-33.43%	0.14%
ROIC Less NNEP Spread (ROIC-NNEP)	59.28%	84.14%	94.61%	61.56%	44.13%	-24.43%	42.62%	20.07%	-68.22%	5.19%
Return on Net Nonoperating Assets (RNNOA)	6.66%	7.38%	8.79%	7.55%	4.44%	-3.51%	1.15%	0.87%	-5.40%	0.84%
Return on Equity (ROE)	32.42%	32.80%	42.44%	12.17%	-0.01%	-27.29%	-5.96%	-15.11%	-38.83%	0.99%
Cash Return on Invested Capital (CROIC)	-2.16%	23.55%	0.92%	-0.27%	-16.60%	-29.40%	-27.71%	-24.97%	-18.90%	-9.46%
Operating Return on Assets (OROA)	19.49%	18.57%	27.79%	5.00%	-3.37%	-19.74%	-4.37%	-12.76%	-29.88%	3.04%
Return on Assets (ROA)	20.19%	24.55%	29.96%	17.44%	8.39%	-14.60%	0.56%	-4.91%	-28.02%	2.13%
Return on Common Equity (ROCE)	31.33%	31.89%	41.20%	11.81%	-0.01%	-26.59%	-5.19%	-13.17%	-33.66%	0.85%
Return on Equity Simple (ROE_SIMPLE)	24.71%	0.00%	41.36%	41.22%	34.71%	0.00%	3.56%	-3.94%	-17.81%	0.00%
Net Operating Profit after Tax (NOPAT)	689	802	838	104	-98	-595	-126	-345	-776	3.79
NOPAT Margin	32.94%	30.58%	32.48%	4.40%	-4.24%	-25.25%	-9.23%	-24.11%	-57.30%	0.31%
Net Nonoperating Expense Percent (NNEP)	-33.51%	-58.71%	-60.96%	-56.94%	-48.57%	0.65%	-49.72%	-36.04%	34.79%	-5.05%
Return On Investment Capital (ROIC_SIMPLE)	-	7.03%	-	-	-	-4.30%	-	-	-	0.03%
Cost of Revenue to Revenue	50.10%	61.80%	50.53%	76.44%	97.62%	129.88%	97.14%	100.74%	107.68%	88.78%
SG&A Expenses to Revenue	6.43%	5.65%	5.98%	16.75%	7.45%	7.92%	14.32%	11.81%	11.39%	8.11%
R&D to Revenue	0.88%	0.77%	0.79%	0.90%	0.91%	0.97%	1.73%	1.45%	1.65%	1.63%
Operating Expenses to Revenue	7.31%	6.42%	6.77%	17.66%	8.44%	9.21%	16.05%	33.70%	74.17%	10.86%
Earnings before Interest and Taxes (EBIT)	899	879	1,184	194	-129	-815	-130	-459	-1,131	121
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	977	964	1,272	287	-23	-671	-5.85	-321	-968	285
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.52	3.11	2.77	2.64	1.99	1.77	0.00	1.25	1.39	1.31
Price to Tangible Book Value (P/TBV)	6.09	4.08	3.50	3.27	2.45	2.22	0.00	1.57	1.82	1.71
Price to Revenue (P/Rev)	5.44	3.39	2.91	2.68	1.99	1.74	0.00	1.51	1.71	1.88
Price to Earnings (P/E)	19.60	9.22	6.95	6.60	5.92	10.61	0.00	0.00	0.00	0.00
Dividend Yield	0.61%	0.75%	0.73%	0.72%	0.95%	1.12%	1.22%	1.68%	1.69%	1.87%
Earnings Yield	5.10%	10.85%	14.38%	15.15%	16.90%	9.42%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.02	2.91	2.67	2.53	1.88	1.62	0.00	1.18	1.27	1.20
Enterprise Value to Revenue (EV/Rev)	5.63	3.49	2.97	2.74	2.10	1.96	0.00	1.91	2.21	2.57
Enterprise Value to EBITDA (EV/EBITDA)	16.16	8.98	6.98	7.54	8.27	21.83	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	18.91	10.04	7.63	8.35	9.71	43.45	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	25.83	12.33	9.75	10.86	12.90	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	38.93	13.41	10.76	10.00	8.73	14.23	0.00	14.38	23.78	19.65
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	12.33	334.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.48	0.39	0.34	0.35	0.36	0.43	0.30	0.31	0.34	0.34
Long-Term Debt to Equity	0.45	0.39	0.34	0.35	0.34	0.37	0.30	0.31	0.34	0.31
Financial Leverage	0.11	0.09	0.09	0.12	0.10	0.14	0.03	0.04	0.08	0.16
Leverage Ratio	1.92	1.89	1.87	1.93	1.91	1.89	1.72	1.74	1.76	1.76
Compound Leverage Factor	1.85	1.85	1.83	1.68	2.34	2.13	2.23	1.87	1.83	1.11
Debt to Total Capital	32.61%	28.20%	25.49%	25.84%	26.47%	30.12%	23.00%	23.48%	25.38%	25.64%
Short-Term Debt to Total Capital	2.43%	0.02%	0.02%	0.05%	1.17%	4.52%	0.03%	0.02%	0.02%	2.90%
Long-Term Debt to Total Capital	30.18%	28.18%	25.47%	25.80%	25.30%	25.60%	22.97%	23.45%	25.36%	22.73%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.59%	14.89%	15.90%	16.30%
Noncontrolling Interests to Total Capital	2.24%	1.83%	1.94%	2.00%	1.91%	1.83%	1.74%	1.74%	1.78%	1.74%
Common Equity to Total Capital	65.15%	69.97%	72.57%	72.15%	71.62%	68.05%	60.67%	59.89%	56.94%	56.33%
Debt to EBITDA	1.73	1.13	0.87	1.00	1.46	4.82	-7.27	-3.23	-1.75	-3.48
Net Debt to EBITDA	0.42	0.20	0.07	0.08	0.32	2.21	-0.43	-0.49	-0.36	-1.19
Long-Term Debt to EBITDA	1.60	1.13	0.87	1.00	1.39	4.10	-7.26	-3.22	-1.75	-3.09
Debt to NOPAT	2.76	1.55	1.21	1.44	2.27	-22.24	-4.89	-3.03	-1.94	-2.83
Net Debt to NOPAT	0.68	0.27	0.10	0.12	0.50	-10.18	-0.29	-0.46	-0.39	-0.97
Long-Term Debt to NOPAT	2.56	1.55	1.21	1.44	2.17	-18.90	-4.88	-3.03	-1.94	-2.51
Altman Z-Score	3.89	3.41	3.37	3.00	2.62	2.19	0.00	2.02	1.75	1.89
Noncontrolling Interest Sharing Ratio	3.37%	2.78%	2.94%	2.98%	2.90%	2.58%	12.93%	12.83%	13.31%	13.72%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.73	1.89	1.90	1.74	1.81	1.47	2.84	2.67	2.44	1.95
Quick Ratio	1.03	1.05	0.93	0.79	0.84	0.73	1.64	1.55	1.40	1.10
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-685	802	-1,756	-2,355	-3,270	-3,409	-2,430	-1,991	-1,041	155
Operating Cash Flow to CapEx	285.74%	213.65%	173.48%	14.63%	115.20%	-14.36%	16.91%	81.07%	79.36%	0.19%
Free Cash Flow to Firm to Interest Expense	-23.07	33.35	-65.56	-92.08	-111.49	-99.15	-64.00	-56.59	-21.80	3.48
Operating Cash Flow to Interest Expense	30.15	39.61	26.93	2.88	21.44	-2.86	2.58	10.31	5.04	0.02
Operating Cash Flow Less CapEx to Interest Expense	19.60	21.07	11.40	-16.81	2.83	-22.75	-12.68	-2.41	-1.31	-7.94
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.45	0.55	0.61	0.61	0.60	0.57	0.46	0.40	0.36	0.31
Accounts Receivable Turnover	6.40	7.32	7.33	6.76	6.87	6.21	5.64	5.02	4.77	3.98
Inventory Turnover	2.78	2.95	2.32	2.37	2.79	3.98	3.32	2.96	2.88	2.90
Fixed Asset Turnover	0.93	1.14	1.31	1.37	1.34	1.17	0.98	0.84	0.74	0.57
Accounts Payable Turnover	2.99	3.14	2.69	2.79	3.28	4.07	4.16	3.69	3.80	3.51
Days Sales Outstanding (DSO)	57.03	49.86	49.81	53.97	53.16	58.81	64.70	72.65	76.52	91.73
Days Inventory Outstanding (DIO)	131.17	123.57	157.17	153.84	131.01	91.72	109.85	123.32	126.87	125.80
Days Payable Outstanding (DPO)	122.16	116.06	135.52	130.78	111.19	89.61	87.84	98.85	95.99	104.11
Cash Conversion Cycle (CCC)	66.04	57.37	71.46	77.03	72.99	60.91	86.71	97.12	107.39	113.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,839	8,804	9,763	10,429	11,012	11,619	12,068	12,076	11,277	11,467
Invested Capital Turnover	0.78	0.83	1.04	1.05	1.05	0.94	0.77	0.66	0.58	0.47
Increase / (Decrease) in Invested Capital	1,374	0.00	2,594	2,459	3,172	2,814	2,304	1,647	265	-152
Enterprise Value (EV)	31,508	25,577	26,057	26,434	20,737	18,856	0.00	14,254	14,342	13,797
Market Capitalization	30,447	24,802	25,553	25,866	19,670	16,696	0.00	11,226	11,132	10,118
Book Value per Share	$57.48	$68.14	$78.61	$83.65	$84.35	$80.20	$79.16	$76.47	$68.11	$65.73
Tangible Book Value per Share	$42.70	$51.87	$62.24	$67.38	$68.44	$64.09	$63.28	$60.78	$52.08	$50.31
Total Capital	10,335	11,408	12,695	13,604	13,821	13,832	15,324	15,006	14,060	13,716
Total Debt	3,370	3,217	3,236	3,516	3,658	4,167	3,525	3,523	3,569	3,516
Total Long-Term Debt	3,119	3,215	3,233	3,509	3,496	3,541	3,519	3,520	3,566	3,118
Net Debt	829	567	258	294	803	1,907	210	532	725	1,206
Capital Expenditures (CapEx)	313	446	416	504	546	684	579	448	303	356
Debt-free, Cash-free Net Working Capital (DFCFNWC)	677	949	1,568	1,570	1,745	1,392	1,721	1,440	1,097	1,082
Debt-free Net Working Capital (DFNWC)	2,060	2,448	3,154	3,170	3,346	2,282	3,777	3,270	2,762	2,274
Net Working Capital (NWC)	1,809	2,446	3,152	3,163	3,184	1,656	3,772	3,267	2,759	1,876
Net Nonoperating Expense (NNE)	-242	-360	-439	-572	-419	8.39	-142	-168	284	-81
Net Nonoperating Obligations (NNO)	875	614	304	341	849	1,954	268	592	786	1,267
Total Depreciation and Amortization (D&A)	78	86	87	93	105	144	124	138	164	163
Debt-free, Cash-free Net Working Capital to Revenue	12.11%	12.96%	17.87%	16.24%	17.65%	14.48%	20.50%	19.31%	16.88%	20.11%
Debt-free Net Working Capital to Revenue	36.83%	33.44%	35.96%	32.80%	33.86%	23.73%	44.98%	43.85%	42.48%	42.28%
Net Working Capital to Revenue	32.34%	33.41%	35.93%	32.74%	32.22%	17.22%	44.92%	43.81%	42.43%	34.88%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$7.66	$9.68	$10.57	$5.54	$2.58	($5.28)	($0.08)	($1.96)	($9.45)	$0.29
Adjusted Weighted Average Basic Shares Outstanding	117.14M	117.12M	117.23M	117.33M	117.35M	117.32M	117.45M	117.53M	117.54M	117.52M
Adjusted Diluted Earnings per Share	$7.61	$9.62	$10.51	$5.52	$2.57	($5.24)	($0.08)	($1.96)	($9.45)	$0.29
Adjusted Weighted Average Diluted Shares Outstanding	117.87M	117.79M	117.84M	117.77M	117.78M	117.77M	117.45M	117.53M	117.54M	117.52M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	117.15M	0.00	117.34M	117.35M	117.35M	117.40M	117.53M	117.53M	117.54M	117.57M
Normalized Net Operating Profit after Tax (NOPAT)	689	802	838	104	-97	-595	-126	-345	-196	3.79
Normalized NOPAT Margin	32.94%	30.58%	32.48%	4.40%	-4.19%	-25.25%	-9.23%	-24.11%	-14.50%	0.31%
Pre Tax Income Margin	41.56%	32.93%	44.86%	7.10%	-6.85%	-39.09%	-12.32%	-34.55%	-87.02%	6.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	30.28	36.55	44.23	7.58	-4.39	-23.71	-3.41	-13.04	-23.68	2.72
NOPAT to Interest Expense	23.21	33.35	31.30	4.08	-3.34	-17.30	-3.31	-9.80	-16.25	0.08
EBIT Less CapEx to Interest Expense	19.72	18.01	28.71	-12.11	-23.00	-43.61	-18.67	-25.76	-30.03	-5.24
NOPAT Less CapEx to Interest Expense	12.66	14.80	15.78	-15.62	-21.95	-37.20	-18.57	-22.52	-22.60	-7.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	15.80%	8.12%	7.41%	6.34%	7.74%	17.53%	58.54%	-67.29%	-18.22%	-30.69%
Augmented Payout Ratio	15.80%	8.12%	7.41%	6.34%	7.74%	17.53%	58.54%	-67.29%	-18.22%	-30.69%

Frequently Asked Questions About Albemarle's Financials

When does Albemarle's fiscal year end?

According to the most recent income statement we have on file, Albemarle's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Albemarle's net income changed over the last 9 years?

Albemarle's net income appears to be on an upward trend, with a most recent value of -$1.14 billion in 2024, falling from $360.06 million in 2015. The previous period was $1.67 billion in 2023.

What is Albemarle's operating income?

Albemarle's total operating income in 2024 was -$1.78 billion, based on the following breakdown:

Total Gross Profit: $62.54 million
Total Operating Expenses: $1.84 billion

How has Albemarle revenue changed over the last 9 years?

Over the last 9 years, Albemarle's total revenue changed from $2.83 billion in 2015 to $5.38 billion in 2024, a change of 90.3%.

How much debt does Albemarle have?

Albemarle's total liabilities were at $6.41 billion at the end of 2024, a 25.5% decrease from 2023, and a 3.4% increase since 2015.

How much cash does Albemarle have?

In the past 9 years, Albemarle's cash and equivalents has ranged from $213.73 million in 2015 to $2.27 billion in 2016, and is currently $1.19 billion as of their latest financial filing in 2024.

How has Albemarle's book value per share changed over the last 9 years?

Over the last 9 years, Albemarle's book value per share changed from 29.00 in 2015 to 65.73 in 2024, a change of 126.6%.

Remove Ads

Related Companies

This page (NYSE:ALB) was last updated on 4/13/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Albemarle (ALB) Financials

Frequently Asked Questions About Albemarle's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Albemarle (ALB) Financials

Annual Income Statements for Albemarle

Quarterly Income Statements for Albemarle

Annual Cash Flow Statements for Albemarle

Quarterly Cash Flow Statements for Albemarle

Annual Balance Sheets for Albemarle

Quarterly Balance Sheets for Albemarle

Annual Metrics and Ratios for Albemarle

Quarterly Metrics and Ratios for Albemarle

Frequently Asked Questions About Albemarle's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools